NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Supplement·Evidence index

Vitamin K1 and Vitamin K2 MK-4: what the published research says

PubMed indexes 8 records that name Vitamin K1 and Vitamin K2 MK-4 together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Vitamin K1 and Vitamin K2 MK-4. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

8 studies naming Vitamin K1 and Vitamin K2 MK-4.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Menaquinone-4 in breast milk is derived from dietary phylloquinone.

The British journal of nutrition · 2002 · PMID 12064330

Clinical TrialRandomized Controlled Trial

“In conclusion, dietary phylloquinone is a source of menaquinone-4 in breast milk. Phylloquinone supplementation to lactating mothers may be of benefit to the newborn infant, since both phylloquinone and menaquinone-4 are raised by supplementation.”

Thijssen et al. · From the abstract

Names both Vitamin K1 and Vitamin K2 MK-4 in its title.

LC-MS/MS quantitative analysis of phylloquinone, menaquinone-4 and menaquinone-7 in the human serum of a healthy population.

PeerJ · 2019 · PMID 31579595

“Samples were measured from 191 healthy volunteers (51.2 ± 16.2 years (mean ± SD)) and the values concerning K1 were 0.044-1.357 ng/mL for women and 0.030-1.214 ng/mL for men. The values for menaquinone-4 and menaquinone-7 did not exhibit any differences between women and men, and were 0.050-1.598 and 0.074-0.759 ng/mL, respectively.”

Dunovska et al. · From the abstract

Names both Vitamin K1 and Vitamin K2 MK-4 in its title.

Plasma phylloquinone, menaquinone-4 and menaquinone-7 levels and coronary artery calcification.

Journal of nutritional science · 2016 · PMID 28620475

103 participants

“However, CAC did not have a significant correlation with plasma levels of PK, MK-4 or MK-7. In conclusion, plasma MK-7, MK-4 or PK level did not show significant correlation with CAC despite the association between plasma vitamin K levels and vitamin K-dependent proteins such as ucOC or PIVKA-2.”

Torii et al. · From the abstract

Names both Vitamin K1 and Vitamin K2 MK-4 in its title.

Vitamin K1 (phylloquinone) and K2 (menaquinone-4) supplementation improves bone formation in a high-fat diet-induced obese mice.

Journal of clinical biochemistry and nutrition · 2013 · PMID 24062608

“Vitamin K supplementation seems to tend to prevent bone loss in high-fat diet induced obese state. These findings suggest that vitamin K supplementation reversed the high fat diet induced bone deterioration by modulating osteoblast and osteoclast activities and prevent bone loss in a high-fat diet-induced obese mice.”

Kim et al. · From the abstract

Names both Vitamin K1 and Vitamin K2 MK-4 in its title.

Vitamin K1 (phylloquinone) or vitamin K2 (menaquinone-4) induces intestinal alkaline phosphatase gene expression.

Journal of nutritional science and vitaminology · 2011 · PMID 22041909

Animal study

“This is the first report concerning IAP mRNA expression induced by oral administration of vitamin K. The results support the possible involvement of vitamin K in the regulation of IAP mRNA expression as a novel pharmacological effect of vitamin K.”

Haraikawa et al. · From the abstract

Names both Vitamin K1 and Vitamin K2 MK-4 in its title.

Menaquinone-4 accumulation in various tissues after an oral administration of phylloquinone in Wistar rats.

Journal of nutritional science and vitaminology · 1997 · PMID 9151247

Animal study

“This data suggests that the ingested phylloquinone was probably converted into MK-4 within the tissues themselves, rather than via hepatic metabolism. The evidence for this is that, after phylloquinone administration, (i) in each of the tissues, the MK-4 concentration increased much more slowly than that of phylloquinone, and (ii) the MK-4 concentration in the plasma and liver reached only much lower levels than those seen in other tissues.”

Yamamoto et al. · From the abstract

Names both Vitamin K1 and Vitamin K2 MK-4 in its title.

Phylloquinone and menaquinone-4 distribution in rats: synthesis rather than uptake determines menaquinone-4 organ concentrations.

The Journal of nutrition · 1996 · PMID 8632229

Animal study

“Warfarin treatment lowered significantly the MK-4 concentrations, whereas MK-4 epoxide accumulated. The study shows the following: 1) dietary phylloquinone is accumulated mainly in the heart and liver, 2) the MK-4 accumulation in nonhepatic organs is due to synthesis rather than uptake and 3) MK-4 rather than phylloquinone may be the functional vitamin in nonhepatic organs.”

Thijssen et al. · From the abstract

Names both Vitamin K1 and Vitamin K2 MK-4 in its title.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Vitamin K1, Vitamin K2 MK-4, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.